HEADER OXIDOREDUCTASE 10-FEB-21 7E48 TITLE CRYSTAL STRUCTURE OF INHA IN COMPLEX WITH 3-NITROPROPANOIC ACID TITLE 2 INHIBITOR COMPND MOL_ID: 1; COMPND 2 MOLECULE: ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE [NADH]; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: ENOYL-ACP REDUCTASE,FAS-II ENOYL-ACP REDUCTASE,NADH- COMPND 5 DEPENDENT 2-TRANS-ENOYL-ACP REDUCTASE; COMPND 6 EC: 1.3.1.9; COMPND 7 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: MYCOBACTERIUM TUBERCULOSIS (STRAIN ATCC 25618 / SOURCE 3 H37RV); SOURCE 4 ORGANISM_TAXID: 83332; SOURCE 5 GENE: INHA, RV1484, MTCY277.05; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET15B KEYWDS ENOYL-ACP REDUCTASE, FAS-II ENOYL-ACP REDUCTASE, NADH- DEPENDENT 2- KEYWDS 2 TRANS-ENOYL-ACP REDUCTASE, OXIDOREDUCTASE EXPDTA X-RAY DIFFRACTION AUTHOR C.SONGSIRIRITTHIGUL,C.HANWARINROJ,N.SUTTIPANTA,P.KAMSRI,P.KITTAKOOP, AUTHOR 2 P.PUNGPO REVDAT 3 29-NOV-23 7E48 1 REMARK REVDAT 2 23-FEB-22 7E48 1 JRNL REVDAT 1 24-NOV-21 7E48 0 JRNL AUTH C.SONGSIRIRITTHIGUL,C.HANWARINROJ,B.PAKAMWONG,P.SRIMANOTE, JRNL AUTH 2 N.SUTTIPANTA,S.SURERAM,K.SUTTISINTONG,P.KAMSRI,A.PUNKVANG, JRNL AUTH 3 J.SPENCER,P.KITTAKOOP,P.PUNGPO JRNL TITL INHIBITION OF MYCOBACTERIUM TUBERCULOSIS INHA BY JRNL TITL 2 3-NITROPROPANOIC ACID. JRNL REF PROTEINS V. 90 898 2022 JRNL REFN ESSN 1097-0134 JRNL PMID 34677871 JRNL DOI 10.1002/PROT.26268 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.8.0253 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : NULL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 28.76 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 3 NUMBER OF REFLECTIONS : 50088 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : FREE R-VALUE REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING + TEST SET) : NULL REMARK 3 R VALUE (WORKING SET) : 0.185 REMARK 3 FREE R VALUE : 0.220 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.907 REMARK 3 FREE R VALUE TEST SET COUNT : 2458 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.57 REMARK 3 REFLECTION IN BIN (WORKING SET) : 3511 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.97 REMARK 3 BIN R VALUE (WORKING SET) : 0.2940 REMARK 3 BIN FREE R VALUE SET COUNT : 160 REMARK 3 BIN FREE R VALUE : 0.3210 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 7953 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 214 REMARK 3 SOLVENT ATOMS : 369 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 34.88 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 0.08100 REMARK 3 B22 (A**2) : 0.08100 REMARK 3 B33 (A**2) : -0.26300 REMARK 3 B12 (A**2) : 0.04100 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.378 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.237 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.188 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 9.034 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.949 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.930 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 8399 ; 0.002 ; 0.013 REMARK 3 BOND LENGTHS OTHERS (A): 7900 ; 0.001 ; 0.017 REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 11442 ; 1.173 ; 1.637 REMARK 3 BOND ANGLES OTHERS (DEGREES): 18287 ; 1.095 ; 1.575 REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 1084 ; 6.139 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 376 ;29.568 ;21.809 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 1339 ;13.820 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 55 ;17.598 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 1135 ; 0.038 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 9491 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): 1694 ; 0.001 ; 0.020 REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1889 ; 0.170 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): 87 ; 0.216 ; 0.200 REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 4009 ; 0.146 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 421 ; 0.134 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 4290 ; 0.710 ; 3.718 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): 4289 ; 0.710 ; 3.718 REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 5361 ; 1.256 ; 5.576 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): 5362 ; 1.256 ; 5.577 REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 4109 ; 0.701 ; 3.800 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): 4110 ; 0.701 ; 3.800 REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 6070 ; 1.259 ; 5.645 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): 6071 ; 1.259 ; 5.646 REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK BULK SOLVENT REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THEIR REMARK 3 RIDING POSITIONS REMARK 4 REMARK 4 7E48 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 17-FEB-21. REMARK 100 THE DEPOSITION ID IS D_1300020732. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 22-JAN-18 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLRI REMARK 200 BEAMLINE : BL7.2W REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.24 REMARK 200 MONOCHROMATOR : DCM REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MAR CCD 165 MM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM IMOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 50117 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 28.760 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 2.600 REMARK 200 R MERGE (I) : 0.08600 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 8.3000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.64 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : 0.42000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 2.300 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: 6R9W REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 60.50 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 3.11 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PURIFIED PROTEIN INCUBATED WITH NADH REMARK 280 AND 3NP IN 5% (W/V) ETHANOL, 5% (W/V) MPD, 200MM SODIUM CHLORIDE, REMARK 280 100MM TRIS-HCL PH 8.5, MICROBATCH, TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -Y,X-Y,Z+2/3 REMARK 290 3555 -X+Y,-X,Z+1/3 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000 REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 93.00000 REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000 REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 46.50000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 20460 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 32680 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -125.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 THR A 2 REMARK 465 MET B 1 REMARK 465 THR B 2 REMARK 465 MET C 1 REMARK 465 THR C 2 REMARK 465 MET D 1 REMARK 465 THR D 2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 O HIS A 265 NE ARG B 153 2.14 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 42 -75.88 72.11 REMARK 500 PRO A 99 153.09 -47.89 REMARK 500 ASN A 106 109.55 -51.07 REMARK 500 ASP A 150 107.99 -42.80 REMARK 500 ALA A 157 -48.21 75.49 REMARK 500 ASN A 159 -111.76 47.83 REMARK 500 ASP B 42 -76.88 76.30 REMARK 500 ASN B 106 109.47 -51.40 REMARK 500 ASP B 150 104.52 -38.34 REMARK 500 ALA B 157 -44.20 78.45 REMARK 500 ASN B 159 -113.68 48.01 REMARK 500 ALA B 226 109.15 -53.63 REMARK 500 ASP C 42 -77.59 75.04 REMARK 500 PRO C 99 154.97 -49.80 REMARK 500 ASN C 106 106.22 -51.01 REMARK 500 ASP C 150 107.39 -41.03 REMARK 500 ALA C 157 -45.70 74.50 REMARK 500 ASN C 159 -113.79 47.28 REMARK 500 ASP D 42 -74.89 73.87 REMARK 500 ASN D 106 107.03 -48.82 REMARK 500 ASP D 150 107.10 -39.62 REMARK 500 ALA D 157 -47.56 76.61 REMARK 500 ASN D 159 -114.06 48.15 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 6R9W RELATED DB: PDB DBREF 7E48 A 1 269 UNP P9WGR1 INHA_MYCTU 1 269 DBREF 7E48 B 1 269 UNP P9WGR1 INHA_MYCTU 1 269 DBREF 7E48 C 1 269 UNP P9WGR1 INHA_MYCTU 1 269 DBREF 7E48 D 1 269 UNP P9WGR1 INHA_MYCTU 1 269 SEQRES 1 A 269 MET THR GLY LEU LEU ASP GLY LYS ARG ILE LEU VAL SER SEQRES 2 A 269 GLY ILE ILE THR ASP SER SER ILE ALA PHE HIS ILE ALA SEQRES 3 A 269 ARG VAL ALA GLN GLU GLN GLY ALA GLN LEU VAL LEU THR SEQRES 4 A 269 GLY PHE ASP ARG LEU ARG LEU ILE GLN ARG ILE THR ASP SEQRES 5 A 269 ARG LEU PRO ALA LYS ALA PRO LEU LEU GLU LEU ASP VAL SEQRES 6 A 269 GLN ASN GLU GLU HIS LEU ALA SER LEU ALA GLY ARG VAL SEQRES 7 A 269 THR GLU ALA ILE GLY ALA GLY ASN LYS LEU ASP GLY VAL SEQRES 8 A 269 VAL HIS SER ILE GLY PHE MET PRO GLN THR GLY MET GLY SEQRES 9 A 269 ILE ASN PRO PHE PHE ASP ALA PRO TYR ALA ASP VAL SER SEQRES 10 A 269 LYS GLY ILE HIS ILE SER ALA TYR SER TYR ALA SER MET SEQRES 11 A 269 ALA LYS ALA LEU LEU PRO ILE MET ASN PRO GLY GLY SER SEQRES 12 A 269 ILE VAL GLY MET ASP PHE ASP PRO SER ARG ALA MET PRO SEQRES 13 A 269 ALA TYR ASN TRP MET THR VAL ALA LYS SER ALA LEU GLU SEQRES 14 A 269 SER VAL ASN ARG PHE VAL ALA ARG GLU ALA GLY LYS TYR SEQRES 15 A 269 GLY VAL ARG SER ASN LEU VAL ALA ALA GLY PRO ILE ARG SEQRES 16 A 269 THR LEU ALA MET SER ALA ILE VAL GLY GLY ALA LEU GLY SEQRES 17 A 269 GLU GLU ALA GLY ALA GLN ILE GLN LEU LEU GLU GLU GLY SEQRES 18 A 269 TRP ASP GLN ARG ALA PRO ILE GLY TRP ASN MET LYS ASP SEQRES 19 A 269 ALA THR PRO VAL ALA LYS THR VAL CYS ALA LEU LEU SER SEQRES 20 A 269 ASP TRP LEU PRO ALA THR THR GLY ASP ILE ILE TYR ALA SEQRES 21 A 269 ASP GLY GLY ALA HIS THR GLN LEU LEU SEQRES 1 B 269 MET THR GLY LEU LEU ASP GLY LYS ARG ILE LEU VAL SER SEQRES 2 B 269 GLY ILE ILE THR ASP SER SER ILE ALA PHE HIS ILE ALA SEQRES 3 B 269 ARG VAL ALA GLN GLU GLN GLY ALA GLN LEU VAL LEU THR SEQRES 4 B 269 GLY PHE ASP ARG LEU ARG LEU ILE GLN ARG ILE THR ASP SEQRES 5 B 269 ARG LEU PRO ALA LYS ALA PRO LEU LEU GLU LEU ASP VAL SEQRES 6 B 269 GLN ASN GLU GLU HIS LEU ALA SER LEU ALA GLY ARG VAL SEQRES 7 B 269 THR GLU ALA ILE GLY ALA GLY ASN LYS LEU ASP GLY VAL SEQRES 8 B 269 VAL HIS SER ILE GLY PHE MET PRO GLN THR GLY MET GLY SEQRES 9 B 269 ILE ASN PRO PHE PHE ASP ALA PRO TYR ALA ASP VAL SER SEQRES 10 B 269 LYS GLY ILE HIS ILE SER ALA TYR SER TYR ALA SER MET SEQRES 11 B 269 ALA LYS ALA LEU LEU PRO ILE MET ASN PRO GLY GLY SER SEQRES 12 B 269 ILE VAL GLY MET ASP PHE ASP PRO SER ARG ALA MET PRO SEQRES 13 B 269 ALA TYR ASN TRP MET THR VAL ALA LYS SER ALA LEU GLU SEQRES 14 B 269 SER VAL ASN ARG PHE VAL ALA ARG GLU ALA GLY LYS TYR SEQRES 15 B 269 GLY VAL ARG SER ASN LEU VAL ALA ALA GLY PRO ILE ARG SEQRES 16 B 269 THR LEU ALA MET SER ALA ILE VAL GLY GLY ALA LEU GLY SEQRES 17 B 269 GLU GLU ALA GLY ALA GLN ILE GLN LEU LEU GLU GLU GLY SEQRES 18 B 269 TRP ASP GLN ARG ALA PRO ILE GLY TRP ASN MET LYS ASP SEQRES 19 B 269 ALA THR PRO VAL ALA LYS THR VAL CYS ALA LEU LEU SER SEQRES 20 B 269 ASP TRP LEU PRO ALA THR THR GLY ASP ILE ILE TYR ALA SEQRES 21 B 269 ASP GLY GLY ALA HIS THR GLN LEU LEU SEQRES 1 C 269 MET THR GLY LEU LEU ASP GLY LYS ARG ILE LEU VAL SER SEQRES 2 C 269 GLY ILE ILE THR ASP SER SER ILE ALA PHE HIS ILE ALA SEQRES 3 C 269 ARG VAL ALA GLN GLU GLN GLY ALA GLN LEU VAL LEU THR SEQRES 4 C 269 GLY PHE ASP ARG LEU ARG LEU ILE GLN ARG ILE THR ASP SEQRES 5 C 269 ARG LEU PRO ALA LYS ALA PRO LEU LEU GLU LEU ASP VAL SEQRES 6 C 269 GLN ASN GLU GLU HIS LEU ALA SER LEU ALA GLY ARG VAL SEQRES 7 C 269 THR GLU ALA ILE GLY ALA GLY ASN LYS LEU ASP GLY VAL SEQRES 8 C 269 VAL HIS SER ILE GLY PHE MET PRO GLN THR GLY MET GLY SEQRES 9 C 269 ILE ASN PRO PHE PHE ASP ALA PRO TYR ALA ASP VAL SER SEQRES 10 C 269 LYS GLY ILE HIS ILE SER ALA TYR SER TYR ALA SER MET SEQRES 11 C 269 ALA LYS ALA LEU LEU PRO ILE MET ASN PRO GLY GLY SER SEQRES 12 C 269 ILE VAL GLY MET ASP PHE ASP PRO SER ARG ALA MET PRO SEQRES 13 C 269 ALA TYR ASN TRP MET THR VAL ALA LYS SER ALA LEU GLU SEQRES 14 C 269 SER VAL ASN ARG PHE VAL ALA ARG GLU ALA GLY LYS TYR SEQRES 15 C 269 GLY VAL ARG SER ASN LEU VAL ALA ALA GLY PRO ILE ARG SEQRES 16 C 269 THR LEU ALA MET SER ALA ILE VAL GLY GLY ALA LEU GLY SEQRES 17 C 269 GLU GLU ALA GLY ALA GLN ILE GLN LEU LEU GLU GLU GLY SEQRES 18 C 269 TRP ASP GLN ARG ALA PRO ILE GLY TRP ASN MET LYS ASP SEQRES 19 C 269 ALA THR PRO VAL ALA LYS THR VAL CYS ALA LEU LEU SER SEQRES 20 C 269 ASP TRP LEU PRO ALA THR THR GLY ASP ILE ILE TYR ALA SEQRES 21 C 269 ASP GLY GLY ALA HIS THR GLN LEU LEU SEQRES 1 D 269 MET THR GLY LEU LEU ASP GLY LYS ARG ILE LEU VAL SER SEQRES 2 D 269 GLY ILE ILE THR ASP SER SER ILE ALA PHE HIS ILE ALA SEQRES 3 D 269 ARG VAL ALA GLN GLU GLN GLY ALA GLN LEU VAL LEU THR SEQRES 4 D 269 GLY PHE ASP ARG LEU ARG LEU ILE GLN ARG ILE THR ASP SEQRES 5 D 269 ARG LEU PRO ALA LYS ALA PRO LEU LEU GLU LEU ASP VAL SEQRES 6 D 269 GLN ASN GLU GLU HIS LEU ALA SER LEU ALA GLY ARG VAL SEQRES 7 D 269 THR GLU ALA ILE GLY ALA GLY ASN LYS LEU ASP GLY VAL SEQRES 8 D 269 VAL HIS SER ILE GLY PHE MET PRO GLN THR GLY MET GLY SEQRES 9 D 269 ILE ASN PRO PHE PHE ASP ALA PRO TYR ALA ASP VAL SER SEQRES 10 D 269 LYS GLY ILE HIS ILE SER ALA TYR SER TYR ALA SER MET SEQRES 11 D 269 ALA LYS ALA LEU LEU PRO ILE MET ASN PRO GLY GLY SER SEQRES 12 D 269 ILE VAL GLY MET ASP PHE ASP PRO SER ARG ALA MET PRO SEQRES 13 D 269 ALA TYR ASN TRP MET THR VAL ALA LYS SER ALA LEU GLU SEQRES 14 D 269 SER VAL ASN ARG PHE VAL ALA ARG GLU ALA GLY LYS TYR SEQRES 15 D 269 GLY VAL ARG SER ASN LEU VAL ALA ALA GLY PRO ILE ARG SEQRES 16 D 269 THR LEU ALA MET SER ALA ILE VAL GLY GLY ALA LEU GLY SEQRES 17 D 269 GLU GLU ALA GLY ALA GLN ILE GLN LEU LEU GLU GLU GLY SEQRES 18 D 269 TRP ASP GLN ARG ALA PRO ILE GLY TRP ASN MET LYS ASP SEQRES 19 D 269 ALA THR PRO VAL ALA LYS THR VAL CYS ALA LEU LEU SER SEQRES 20 D 269 ASP TRP LEU PRO ALA THR THR GLY ASP ILE ILE TYR ALA SEQRES 21 D 269 ASP GLY GLY ALA HIS THR GLN LEU LEU HET NAD A 301 44 HET 3NP A 302 8 HET NAD B 301 44 HET 3NP B 302 8 HET GOL B 303 6 HET NAD C 301 44 HET 3NP C 302 8 HET NAD D 301 44 HET 3NP D 302 8 HETNAM NAD NICOTINAMIDE-ADENINE-DINUCLEOTIDE HETNAM 3NP 3-NITROPROPANOIC ACID HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 5 NAD 4(C21 H27 N7 O14 P2) FORMUL 6 3NP 4(C3 H5 N O4) FORMUL 9 GOL C3 H8 O3 FORMUL 14 HOH *369(H2 O) HELIX 1 AA1 SER A 20 GLN A 32 1 13 HELIX 2 AA2 ARG A 43 ASP A 52 1 10 HELIX 3 AA3 ASN A 67 GLY A 83 1 17 HELIX 4 AA4 PRO A 99 MET A 103 5 5 HELIX 5 AA5 PRO A 107 ALA A 111 5 5 HELIX 6 AA6 PRO A 112 ALA A 124 1 13 HELIX 7 AA7 ALA A 124 LEU A 135 1 12 HELIX 8 AA8 TYR A 158 TYR A 182 1 25 HELIX 9 AA9 THR A 196 GLY A 204 1 9 HELIX 10 AB1 GLY A 208 ALA A 226 1 19 HELIX 11 AB2 ALA A 235 SER A 247 1 13 HELIX 12 AB3 GLY A 263 GLN A 267 5 5 HELIX 13 AB4 SER B 20 GLN B 32 1 13 HELIX 14 AB5 ARG B 43 ASP B 52 1 10 HELIX 15 AB6 ASN B 67 GLY B 83 1 17 HELIX 16 AB7 PRO B 99 MET B 103 5 5 HELIX 17 AB8 PRO B 107 ALA B 111 5 5 HELIX 18 AB9 PRO B 112 ALA B 124 1 13 HELIX 19 AC1 ALA B 124 LEU B 135 1 12 HELIX 20 AC2 TYR B 158 TYR B 182 1 25 HELIX 21 AC3 THR B 196 GLY B 204 1 9 HELIX 22 AC4 GLY B 208 ALA B 226 1 19 HELIX 23 AC5 ALA B 235 SER B 247 1 13 HELIX 24 AC6 GLY B 263 GLN B 267 5 5 HELIX 25 AC7 SER C 20 GLN C 32 1 13 HELIX 26 AC8 ARG C 43 ASP C 52 1 10 HELIX 27 AC9 ASN C 67 GLY C 83 1 17 HELIX 28 AD1 PRO C 99 MET C 103 5 5 HELIX 29 AD2 PRO C 107 ALA C 111 5 5 HELIX 30 AD3 PRO C 112 ALA C 124 1 13 HELIX 31 AD4 ALA C 124 LEU C 135 1 12 HELIX 32 AD5 TYR C 158 TYR C 182 1 25 HELIX 33 AD6 THR C 196 GLY C 204 1 9 HELIX 34 AD7 GLY C 208 ALA C 226 1 19 HELIX 35 AD8 ALA C 235 SER C 247 1 13 HELIX 36 AD9 GLY C 263 GLN C 267 5 5 HELIX 37 AE1 SER D 20 GLN D 32 1 13 HELIX 38 AE2 ARG D 43 ASP D 52 1 10 HELIX 39 AE3 ASN D 67 GLY D 83 1 17 HELIX 40 AE4 PRO D 99 MET D 103 5 5 HELIX 41 AE5 PRO D 107 ALA D 111 5 5 HELIX 42 AE6 PRO D 112 ALA D 124 1 13 HELIX 43 AE7 ALA D 124 LEU D 135 1 12 HELIX 44 AE8 TYR D 158 TYR D 182 1 25 HELIX 45 AE9 THR D 196 GLY D 204 1 9 HELIX 46 AF1 GLY D 208 ALA D 226 1 19 HELIX 47 AF2 ALA D 235 SER D 247 1 13 HELIX 48 AF3 GLY D 263 GLN D 267 5 5 SHEET 1 AA1 7 LEU A 60 GLU A 62 0 SHEET 2 AA1 7 GLN A 35 GLY A 40 1 N LEU A 38 O LEU A 61 SHEET 3 AA1 7 ARG A 9 VAL A 12 1 N VAL A 12 O VAL A 37 SHEET 4 AA1 7 LEU A 88 HIS A 93 1 O ASP A 89 N ARG A 9 SHEET 5 AA1 7 MET A 138 ASP A 148 1 O VAL A 145 N HIS A 93 SHEET 6 AA1 7 ARG A 185 ALA A 191 1 O VAL A 189 N ASP A 148 SHEET 7 AA1 7 ASP A 256 ALA A 260 1 O ILE A 258 N LEU A 188 SHEET 1 AA2 7 LEU B 60 GLU B 62 0 SHEET 2 AA2 7 GLN B 35 GLY B 40 1 N LEU B 38 O LEU B 61 SHEET 3 AA2 7 ARG B 9 VAL B 12 1 N VAL B 12 O VAL B 37 SHEET 4 AA2 7 LEU B 88 HIS B 93 1 O ASP B 89 N ARG B 9 SHEET 5 AA2 7 MET B 138 ASP B 148 1 O VAL B 145 N HIS B 93 SHEET 6 AA2 7 ARG B 185 ALA B 191 1 O VAL B 189 N ASP B 148 SHEET 7 AA2 7 ASP B 256 ALA B 260 1 O ILE B 258 N ALA B 190 SHEET 1 AA3 7 LEU C 60 GLU C 62 0 SHEET 2 AA3 7 GLN C 35 GLY C 40 1 N LEU C 38 O LEU C 61 SHEET 3 AA3 7 ARG C 9 VAL C 12 1 N VAL C 12 O VAL C 37 SHEET 4 AA3 7 LEU C 88 HIS C 93 1 O ASP C 89 N ARG C 9 SHEET 5 AA3 7 MET C 138 ASP C 148 1 O VAL C 145 N HIS C 93 SHEET 6 AA3 7 ARG C 185 ALA C 191 1 O VAL C 189 N ASP C 148 SHEET 7 AA3 7 ASP C 256 ALA C 260 1 O ILE C 258 N LEU C 188 SHEET 1 AA4 7 LEU D 60 GLU D 62 0 SHEET 2 AA4 7 GLN D 35 GLY D 40 1 N LEU D 38 O LEU D 61 SHEET 3 AA4 7 ARG D 9 VAL D 12 1 N VAL D 12 O VAL D 37 SHEET 4 AA4 7 LEU D 88 HIS D 93 1 O ASP D 89 N ARG D 9 SHEET 5 AA4 7 MET D 138 ASP D 148 1 O VAL D 145 N HIS D 93 SHEET 6 AA4 7 ARG D 185 ALA D 191 1 O ARG D 185 N ILE D 144 SHEET 7 AA4 7 ASP D 256 ALA D 260 1 O ILE D 258 N LEU D 188 CRYST1 96.390 96.390 139.500 90.00 90.00 120.00 P 32 12 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.010375 0.005990 0.000000 0.00000 SCALE2 0.000000 0.011979 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007168 0.00000